Cigna Corporation (CI)

CI's first-quarter results are likely to have benefited from growing pharmacy revenues and fees.

Besides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarte...

Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HOUSTON--(BUSINESS WIRE)--Cigna Healthcare (Cigna) and Radiology Partners-affiliated practice, Singleton Associates, P.A. (Singleton), have entered into a new multi-year agreement, effective June 1, 2...

The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat...

Canada's Competition Bureau said on Friday it has launched an investigation into Cigna's pharmacy benefit management unit Express Scripts.

Cigna's strong growth, favorable valuation, and shareholder policies justify a "buy" rating, outperforming the S&P500 with a 37% return since May 2023. The integration of insurance with pharmacy benef...

NEW YORK--(BUSINESS WIRE)--Cigna Healthcare has selected Baron Capital, a premier asset management firm focused exclusively on delivering growth equity investment solutions to institutions, financial ...

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth by reducing Medicare exposure and improving Commercial business. Despite industry challenges, Cigna...

AIN, EFX and CI have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2025.